Marchex, Inc. MCHX
1.31
0.00
0.00%
as of 25 Sep
- Market cap
- $58.1M
- P/E
- 0.0×
Follow MCHX
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
1.62 | 1.53 | 1.60 | 1.71 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(109.93) | (132.57) | 601.72 | 274.05 | |
P/B ratio |
2.46 | 2.36 | 2.42 | 2.49 | |
Price to Tangible BV |
6.22 | 6.03 | 5.81 | 5.53 | |
EV/Sales |
1.46 | 1.34 | 1.40 | 1.51 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(85.16) | 85.66 | (45.25) | (107.03) | |
EV/FCF |
(28.17) | (77.08) | (23.32) | (40.81) | |
Quick Ratio |
2.00 | 1.94 | 2.06 | 2.20 | |
Current Ratio |
2.29 | 2.22 | 2.36 | 2.53 | |
Net Debt/EBITDA |
(38.27) | 14.18 | 5.92 | 13.74 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
1.10 | 1.13 | 1.10 | 1.09 | |
Operating CF/Net income |
1.59 | 0.30 | (0.05) | (0.28) | |
Capex/Depreciation |
(0.70) | (0.62) | (0.61) | (1.34) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
18.10% | 22.67% | 20.32% | 20.58% | |
Selling, General and Administrative Expense of Revenue |
45.02% | 50.52% | 50.31% | 50.71% | |
Intangible Assets out of Total Assets |
0.47 | 0.46 | 0.44 | 0.43 | |
Share Based Compensation of Revenue |
4.83% | 4.61% | 4.20% | 7.99% | |
Graham Net Nets |
0.12 | 0.12 | 0.13 | 0.14 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(7.45%) | (6.97%) | (7.11%) | (5.97%) | |
Free Cash Flow Yield |
(3.19%) | (1.14%) | (3.75%) | (2.16%) | |
Revenue per Share |
0.25 | 0.24 | 0.25 | 0.26 | |
Operating CF per Share |
(0.01) | (0.01) | 0.00 | 0.01 | |
Capex per Share |
(0.01) | (0.01) | (0.01) | (0.01) | |
Free Cash Flow per Share |
(0.02) | (0.02) | (0.01) | 0.00 | |
Cash per Share |
0.18 | 0.21 | 0.23 | 0.24 | |
Shareholders Equity per Share |
0.66 | 0.66 | 0.69 | 0.73 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.66 | 0.66 | 0.69 | 0.73 | |
Free Cash Flow |
(1.04) | (0.96) | (0.31) | 0.04 | |
Working Capital |
9.84 | 9.96 | 10.97 | 12.34 | |
Capital Expenditures |
(0.39) | (0.44) | (0.43) | (0.25) | |
Net Current Asset Value |
8.84 | 8.45 | 9.44 | 11.20 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.04 | 0.04 | 0.04 | 0.02 | |
Net Profit Margin |
(3.71%) | (16.24%) | (21.37%) | (8.86%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
7.31 | 7.21 | 6.87 | 7.58 | |
Average Payables |
3.08 | 2.35 | 2.27 | 1.92 | |
Average Assets |
39.81 | 39.59 | 41.44 | 42.61 | |
Average Common Equity |
30.54 | 30.11 | 31.36 | 33.03 |
Columns are period end dates